Annual Shareholders Equity
$49.91 M
+$3.67 M+7.93%
01 December 2023
Summary:
Opus Genetics annual stockholders equity is currently $49.91 million, with the most recent change of +$3.67 million (+7.93%) on 01 December 2023. During the last 3 years, it has risen by +$27.68 million (+124.58%).IRD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$34.30 M
-$6.34 M-15.59%
01 September 2024
Summary:
Opus Genetics quarterly stockholders equity is currently $34.30 million, with the most recent change of -$6.34 million (-15.59%) on 01 September 2024. Over the past year, it has dropped by -$15.61 million (-31.27%).IRD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IRD Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -31.3% |
| 3 y3 years | +124.6% | +54.4% |
| 5 y5 years | +760.1% | - |
IRD Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -31.8% |
Opus Genetics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $34.30 M(-15.6%) |
| June 2024 | - | $40.64 M(-11.8%) |
| Mar 2024 | - | $46.06 M(-7.7%) |
| Dec 2023 | $49.91 M(+7.9%) | $49.91 M(-0.7%) |
| Sept 2023 | - | $50.28 M(+33.4%) |
| June 2023 | - | $37.70 M(-8.6%) |
| Mar 2023 | - | $41.25 M(-10.8%) |
| Dec 2022 | $46.24 M | $46.24 M(+289.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $11.88 M(-18.6%) |
| June 2022 | - | $14.60 M(-15.5%) |
| Mar 2022 | - | $17.27 M(-22.3%) |
| Dec 2021 | $22.22 M(-265.0%) | $22.22 M(+8.1%) |
| Sept 2021 | - | $20.57 M(-8.8%) |
| June 2021 | - | $22.55 M(+129.8%) |
| Mar 2021 | - | $9.82 M(-172.9%) |
| Dec 2020 | -$13.47 M(+78.1%) | -$13.47 M |
| Dec 2019 | -$7.56 M | - |
FAQ
- What is Opus Genetics annual stockholders equity?
- What is the all time high annual shareholders equity for Opus Genetics?
- What is Opus Genetics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Opus Genetics?
- What is Opus Genetics quarterly shareholders equity year-on-year change?
What is Opus Genetics annual stockholders equity?
The current annual shareholders equity of IRD is $49.91 M
What is the all time high annual shareholders equity for Opus Genetics?
Opus Genetics all-time high annual stockholders equity is $49.91 M
What is Opus Genetics quarterly stockholders equity?
The current quarterly shareholders equity of IRD is $34.30 M
What is the all time high quarterly shareholders equity for Opus Genetics?
Opus Genetics all-time high quarterly stockholders equity is $50.28 M
What is Opus Genetics quarterly shareholders equity year-on-year change?
Over the past year, IRD quarterly stockholders equity has changed by -$15.61 M (-31.27%)